社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
雅诗兰黛(EL)
盘后
88.90
-0.05
-0.05%
19:50 EDT
88.95
-1.57
-1.73%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
从你的全世界路过摔了一跤
·
05-23
$雅诗兰黛(EL)$
雅诗兰黛的大涨是否代表着消费情绪的上涨📈?从宏观经济角度看现在还处于五月中下旬这市场低迷的阶段,要是端午节过后才能知道消费情绪是否反弹,谨慎做多
$雅诗兰黛(EL)$ 雅诗兰黛的大涨是否代表着消费情绪的上涨📈?从宏观经济角度看现在还处于五月中下旬这市场低迷的阶段,要是端午节过后才能知道消费情绪是否反...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
星岛财经
·
05-15
IPO前夕大额分红!雅诗兰黛供应商闯关北交所,两轮问询深挖增长真实性
雅诗兰黛 近期,国内化妆品多肽原料领域的头部企业深圳市维琪科技股份有限公司(下称“维琪科技”),顺利通过北交所上市委审核,有望冲刺A股“多肽原料第一股”。 图片 ▲资料来源:北交所 伴随A股消费类IPO政策回暖,北交所成为细分消费企业资本化的重要承接阵地。不过本次IPO进程中,维琪科技先后遭遇两轮监管问询、收入真实性被重点核查,叠加上市申报阶段大额分红、问询后大幅缩减募资规模等争议,公司经营稳定性、资本规划合理性持续受到市场关注。 针对募资调整、未来发展等相关问题,《星岛》向维琪科技发送采访函,截至发稿未获企业回复。 消费IPO迎政策窗口期 近年来A股消费企业上市审核整体趋严。2023年8月27日,中国证监会发布《证监会统筹一二级市场平衡,优化IPO、再融资监管安排》,明确提出根据近期市场情况,阶段性收紧IPO节奏,促进投融资两端的动态平衡。据第三方统计,“827”新政后,至少十余家衣食住行大消费类企业终止了A股IPO项目,不少企业转向境外资本市场递交材料。 转折点出现在2026年3月6日,中国证监会主席吴清在十四届全国人大四次会议经济主题记者会上表示,将在创业板增设一套更加精准、更为包容的上市标准,积极支持新型消费、现代服务业等优质创新创业企业在创业板发行上市。这也被外界解读为消费类IPO开闸的明确信号。 其中,北交所成为了重要承接阵地。数据显示,截至2026年4月3日,北交所排队企业共计152家,与消费服务领域相关的企业就占据23家。市场分析也指出,相较于主板、科创板,北交所财务标准更灵活,侧重考察企业成长潜力与细分竞争力,契合维琪科技这类专精特新消费原料企业的发展阶段。 资料显示,维琪科技成立于2011年,创始人为丁文锋、赖燕华夫妇。公司深耕化妆品多肽、生物活性原料领域多年,核心产品覆盖化妆品多肽原料、生物活性成分及化妆品成品,凭借技术积累切入国际高端供应链。目前,其
IPO前夕大额分红!雅诗兰黛供应商闯关北交所,两轮问询深挖增长真实性
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
野马财经
·
05-06
雅诗兰黛供应商维琪科技年入2亿,70后博士为上市借给前大将600万
为上市无息借给前“大将”600万元。 作者|张德宝 编辑|刘钦文 如果你陪着爱人去过化妆品店,当店员介绍产品时,你一定会听到这样的字样:这款产品不仅具有保湿功效,还兼具美白、修护、抗衰老……,但你是否知道,这些功效的背后大多离不开一种名叫活性多肽的原料。 深圳市维琪科技股份有限公司(简称“维琪科技”)便是以销售活性多肽为主的化妆品原料企业,凭借对化妆品原料的深耕,维琪科技年收入超2亿元。如今,维琪科技站在资本市场大门之外,接受资本市场“检阅”,即将迎来上会。 维琪科技的实控人为丁文锋、赖燕敏夫妇,丁文锋为博士研究生学历。为了成功上市,丁文锋“招兵买马”吸引销售干将和拉不少投资机构入股,但在上市前期一名销售总监与其经营理念不合而退出维琪科技。 而投资机构入股时则伴随着对赌协议,并约定在规定时间未通过上市审核则触发回购条款,将支付4.28亿元回购款。在此之下,丁文锋、赖燕敏能否成功叩开资本市场大门? 01 靠卖化妆品原料年收入超2亿, 丸美、宝洁系客户 根据《招股书》介绍,维琪科技的主要产品为化妆品原料、化妆品成品。其中,化妆品原料产品以皮肤活性多肽为主,化妆品成品业务包括ODM成品业务和OBM成品业务。 其中,维琪科技ODM成品业务指根据客户需求,在向客户销售公司化妆品原料的同时,使用该等原料为客户生产化妆品成品,最终目的系为促进化妆品原料推广和销售。 目前,维琪科技的客户中包含丸美、宝洁、联合利华、敷尔佳等企业。其中,丸美生物常年为维琪科技的第一、第二大客户。数据显示,报告期内,维琪科技来自丸美生物的收入为1579.31万元、2643.6万元、2052.06万元,占当期营收的比重分别为9.58%、10.68%、7.45%。 此外,来自前五大客户的销售收入分别为4858.94万元、9597.58万元、9700.85万元,占当期营收的比重分别为9.58%、10.68%、7.45
雅诗兰黛供应商维琪科技年入2亿,70后博士为上市借给前大将600万
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
源Sight
·
03-18
雅诗兰黛变得越来越小气了
文源 | 源Sight 作者 | 周艺 在祖玛珑创始人和Zara合作了近7年时间后,雅诗兰黛终于坐不住了。 近日,雅诗兰黛起诉了调香师祖·玛珑、其香水品牌Jo Loves以及英国快时尚品牌Zara,原因是他们在香水营销的场景中使用了“祖·玛珑”这一姓名。 在雅诗兰黛看来,会有消费者将Zara与祖·玛珑合作的平价香水与真正的祖玛珑香水混淆,由此起诉祖・玛珑违约、商标侵权及误导消费者。 由于祖・玛珑于1999年将自己的同名香水品牌及姓名使用权出售给雅诗兰黛集团,所以严格意义上讲,任何相关字样出现在同类竞品中,哪怕仅仅说明此款香水由谁打造,也违反了合同条款。 图片来源:Zara官网 2026年,雅诗兰黛对合作伙伴的态度“严苛”了不少,2月份时因为沃尔玛对平台内假货的“放任”态度而发起诉讼;3月份则向Zara和过往品牌创始人“开炮”。 如今的雅诗兰黛还在触底复苏的关键阶段,对蚕食利润和渠道安全的仿冒品不能再视而不见,也不能对试图用平替抢占关键市场的“老同事”网开一面。 在这场降本增效、开源节流的战略行动中,雅诗兰黛大方不起来了。 01 阻断“平替”源头 合作的开始总是甜蜜的。 1999年,当时雅诗兰黛集团主席,也是后期集团的灵魂人物莱纳德意外发现了祖·玛珑生产的浴油,当时其仅仅拥有一个非常小的精品店。 被雅诗兰黛收购之后,祖·玛珑本人也长期担任该香水品牌的创意总监,直到2006年彻底离开,不仅出售了“Jo Malone London”的商标权,还签署了五年不得从事香水行业的竞业协议。 后来,这个决定被祖·玛珑认为是“人生中最大的错误”。 2011年,摆脱竞业协议的祖·玛珑迅速开设了自己的香水品牌,取名“Jo Loves”,瓶身包装与祖玛珑形成较大差别,定价上依然选择了高端奢侈品香水的赛道,部分产品价位高于祖玛珑,主打的受众群体是那些觉得祖玛珑太“大众”的资深香水玩家。 图片来源:淘
雅诗兰黛变得越来越小气了
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
大方财经
·
03-06
雅诗兰黛“变了”
有这样一家美妆巨头,从纽约第五大道的一个小柜台起步,硬是把“高端护肤”做成了全球生意,它就是雅诗兰黛。 1946年,雅诗·兰黛夫人怀揣着对美丽的执着,在纽约第五大道的高端百货中,以一款兼具香水与护肤功效的“青春之露”,敲开了高端美妆市场的大门逐渐发展成如今囊括海蓝之谜、汤姆福特等20多个品牌的美妆帝国。 数十年来,品牌始终坚守高端定位,从伦敦哈罗德百货到全球各地的专柜,从丝芙兰的专属陈列到高端免税店的核心布局,始终以“正品保障、专业品质”为核心,拒绝轻易降价,成为“精致与高端”的代名词。 回望雅诗兰黛的百年发展,其长盛不衰的核心,离不开对消费需求的洞察。从最初精准捕捉上流社会对高端护肤的需求,推出契合圈层审美的产品,到后来紧跟全球化浪潮,布局全品类、多品牌矩阵,每一步都踩准了消费趋势的脉搏。 而在当下,曾经追捧“高端”的消费者,如今更青睐“质价比”——既不愿放弃大牌品质,也不愿为柜台租金、营销费用等虚高溢价埋单。这种“既要又要”的需求,让特卖渠道逐渐崛起,也让雅诗兰黛看到了新的增长可能。 于是在2月25日,雅诗兰黛官宣入驻唯品会。原因很简单,作为特卖电商,唯品会一头解决“省钱买大牌”的现实痛点,一头也给品牌提供了更高效的触达方式:不需要靠极端降价,又能把新品认知和刚需复购覆盖到更广的人群。 比如在唯品会小棕瓶50ml到手价870元还附赠多支小样,智妍面霜75ml到手135ml仅996元,用“正装品质+加量优惠”降低了用户第一次尝试的门槛,让更多人敢试、愿意复购。 平台层面的用户结构也解释了雅诗兰黛的这一动作。唯品会业绩披露,SVIP活跃用户增至980万,并贡献线上销售额的52%。这意味着平台有一批稳定回流的高价值用户,反复在平台下单,对护肤这种高复购品类尤其重要。 除了雅诗兰黛,像兰蔻、蔻驰、巴宝莉等大牌也纷纷下注唯品会,看中的正是特卖背后的广阔蓝海。 说到底,雅诗兰黛们的
雅诗兰黛“变了”
回复
评论
点赞
1
编组 21备份 2
分享
举报
节点美妆
·
03-08
雅诗兰黛硬刚沃尔玛:一场美妆巨头对零售渠道的宣战
文 / 杨蕾 来源 / 节点美妆 “之前在山姆买过一次全球购海蓝之谜,包装很松垮。” “假的是无疑的,我是十年以上资深La Mer用户。” “很廉价的味道,跟专柜买的完全是两样东西。” 最近,随着雅诗兰黛一纸诉状将山姆母公司沃尔玛告上法庭,社交平台上,消费者关于在山姆、沃尔玛买到疑似假货的吐槽集中爆发。 有消费者表示曾考虑自费送检,但被告知检测结果可能不被平台采纳为退货依据;也有消费者反映遇到包装版本不符等情况,沟通解决过程较为周折。 雅诗兰黛此次对沃尔玛的诉讼,将原本零散的个人维权案例带入公众视野,引发更多消费者对高端美妆产品购买渠道的关注。 社交平台上,越来越多消费者晒出照片求助鉴定,从HR赫莲娜黑绷带面霜,到海蓝之谜精粹水,无一不是超一线品牌。 作为品牌方的雅诗兰黛,在此次事件中主动采取法律行动,引发了外界对品牌与渠道关系的讨论。 品牌方与渠道方,本是“唇齿相依”的利益共同体,雅诗兰黛的货要通过沃尔玛、山姆触达消费者,沃尔玛也需要大牌美妆撑场面。 可这一次,雅诗兰黛为何选择撕破脸,硬刚沃尔玛? 雅诗兰黛为何采取法律行动? 美国时间2月9日,雅诗兰黛在加州联邦法院对沃尔玛提起诉讼,指控其通过官方网站销售假冒的旗下香水及护肤品,涉及Le Labo勒莱柏、La Mer海蓝之谜、Clinique倩碧、Tom Ford汤姆福特等多个高客单价品牌。诉状用词极为严厉: 沃尔玛的行为“极端、恶劣、欺诈……卑鄙且有害”。 雅诗兰黛此次态度坚决,背后有多重因素考量。首先,被提及的品牌正是雅诗兰黛的增长引擎。 《节点美妆》在《仰仗中国「辣妹」,雅诗兰黛终于能松口气了》一文中分析雅诗兰黛最新的财报,这个季度雅诗兰黛净销售额增长 6%,达到42 亿美元;有机净销售额增长 4%,在本季度实现1.62亿美元盈利,较去年同期扭亏为盈。 其中香水业务以9%的增速领跑所有部门,主要由Le Labo、To
雅诗兰黛硬刚沃尔玛:一场美妆巨头对零售渠道的宣战
回复
评论
点赞
1
编组 21备份 2
分享
举报
产业经济在线
·
03-06
雅诗兰黛集团于2026 IMCAS 世界大会深化肌肤长寿与再生美学科研领导力
近日,雅诗兰黛集团在 2026年 IMCAS 世界大会上发布了有关「SIRT长寿肌因」(Sirtuin)与外泌体研究的最新科学洞见。作为皮肤科、整形外科与美学领域的顶级学术盛会之一,本届IMCAS 世界大会于1月底在巴黎举办,吸引逾 2 万名参会者,汇聚了行业领军人物的最新科研成果及行业头部企业进展。大会上,集团旗下的雅诗兰黛品牌首席科学家 Rishabh Kala 博士,及海蓝之谜品牌麦克斯·贺伯研究实验室(Max Huber Research Labs)首席科学家 Jaime Emmetsberger 博士受科学委员会邀请发表专题演讲,分别展示了品牌在肌肤长寿科学与再生美学领域的科研权威。 在 Kala 博士题为《肌肤长寿科学:「SIRT长寿肌因」与线粒体健康在皮肤衰老中的科学验证作用》的演讲中,他重点介绍了雅诗兰黛在肌肤长寿科学领域超过 17 年的持续研究,凸显了品牌在该领域的领导地位。「SIRT长寿肌因」(Sirtuins)是一组与健康衰老和长寿密切相关的蛋白质家族,对细胞能量调控、压力应对及稳态维持至关重要。Kala 博士进一步阐释了「SIRT长寿肌因」与线粒体动态在维持年轻肌肤功能中的协同作用,并分享了关于「SIRT长寿肌因」激活机制及线粒体靶向技术的前沿研究进展,这些探索正推动以肌肤长寿为核心的新一代护肤科技发展。雅诗兰黛研究表明,其独有成分能够对抗因年龄增长导致的 SIRT 活性下降,通过支持可见的肌肤逆龄与韧性提升,致力于帮助肌肤细胞维持巅峰状态,保持更长久的年轻健康。 在Emmetsberger 博士题为 《释放外泌体在药妆学中的潜力:替代来源、生物学功效与挑战》的演讲中,她指出外泌体正成为化妆品科学中最受关注的新兴研究领域之一。
雅诗兰黛集团于2026 IMCAS 世界大会深化肌肤长寿与再生美学科研领导力
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
新识研究所
·
02-12
雅诗兰黛起诉沃尔玛,指控销售假冒海蓝之谜、雅诗兰黛、倩碧等美妆产品
雅诗兰黛起诉沃尔玛,指其线上平台售假冒旗下多款美妆产品 近日,雅诗兰黛集团正式向美国加州联邦法院对零售巨头沃尔玛提起诉讼,指控其线上平台销售假冒的海蓝之谜(La Mer)、雅诗兰黛、倩碧等多款核心品牌美妆产品,相关诉讼信息一经发出,迅速引发美妆与零售行业的双重关注。 雅诗兰黛在诉讼中明确要求沃尔玛立即停止侵权行为、销毁假冒产品并作出相应经济赔偿,目前具体赔偿金额尚未对外披露。 针对售假指控,双方已先后表达各自立场。据观点小知报道,沃尔玛方面作出初步回应,称公司对假冒产品持零容忍态度,将在收到法院传票后向法庭作出适当回应,但暂未对平台是否存在管控漏洞作出具体辩解。 雅诗兰黛在诉状中直指沃尔玛的管控失职,称其标榜对平台卖家的选择流程严格,且会定期审核合作卖家,却未落实正品核验的核心义务,同时将沃尔玛的行为形容为“极端、恶劣、具有欺骗性且损害严重”。 这起纠纷的背后,是高端美妆行业长期存在的售假顽疾与渠道管控痛点。据中国经济网发布的美妆鉴别相关报告显示,高端美妆假冒现象屡禁不止,2023年相关美妆检测样本的疑似假货率高达57.7%,且线上零售平台已成为售假重灾区。 目前国内美妆产品真伪鉴别尚无统一国家标准,消费者维权时难以出具官方鉴定报告,超八成买到假货的消费者最终会选择自认倒霉。而相较于品牌官方直供渠道,沃尔玛这类综合零售平台的第三方入驻模式,因卖家审核、产品溯源环节的漏洞,更易成为假冒产品的流通入口,这也是当下线上零售渠道的行业共性问题。 值得注意的是,此次雅诗兰黛起诉沃尔玛,标志着高端美妆行业的打假行动进一步升级。此次直接指向沃尔玛这样的全球零售巨头,意味着品牌方开始正式追究平台的监管连带责任。在美妆消费不断向线上转移的背景下,品牌方的维权思路已从单纯打击制假售假
雅诗兰黛起诉沃尔玛,指控销售假冒海蓝之谜、雅诗兰黛、倩碧等美妆产品
回复
评论
点赞
2
编组 21备份 2
分享
举报
千倍之路
·
02-05
$雅诗兰黛(EL)$
川普还不出手救你的好友?
$雅诗兰黛(EL)$ 川普还不出手救你的好友?
回复
评论
点赞
2
编组 21备份 2
分享
举报
国际投行研究报告
·
02-06
雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌!投资者涌入公用事业和消费必需品类股避险!
雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌! 疲软的劳动力市场数据和对AI的忧虑进一步拉低美国股市,标普500指数年内转跌。软件股也再次大幅下跌;比特币下跌13%,拖累Strategy股价下跌19%。 对增长的担忧周四搅动华尔街,劳动力市场出现疲软迹象,引发美国股市又一天的大幅下跌。 来自政府和私营部门的三份报告显示去年12月份职位空缺意外偏低、上周初申请失业救济人数出人意料高企以及上个月企业裁员人数急剧增加。数据公布后,美国股市普遍下跌。 虽然近期跌势一直集中在市场上一些增长最快的股票类别,但周四的走势冲击了一些之前表现较为坚挺的实体经济类股。与消费者非必需性支出相关的股票跌幅尤其严重,DoorDash下跌6.1%。Lululemon和Ralph Lauren均下跌超过4%。 道琼斯指数下跌近600点,跌幅约1.2%。标普500指数也下跌1.2%,2026年转为下跌。美国国债价格上扬,10年期美国国债收益率随之创下去年10月份以来最大单日跌幅,降至4.209%。 但科技股和华尔街更具投机性的押注也再度下挫。纳斯达克综合指数下跌1.6%,延续了自去年4月份关税冲击以来的最严重跌势。软件股再次大幅下跌。比特币下跌13%,拖累Coinbase创下连续第13个交易日下跌的纪录,并导致比特币囤积公司Strategy股价下跌19%。白银下跌9.1%。 贝雅(Baird)投资策略师罗斯·梅菲尔德(Ross Mayfield)说:“这肯定有一种‘泥沙俱下’的效应。” 标普500指数信息技术板块下跌1.7%。微软(Microsoft)下跌5%,Salesforce回落4.7%。这轮跌势继续冲击半导体公司,包括Advanced Micro Devices,该公司收盘下跌3.9%;以及英伟达(Nvidia),该公司收盘下跌1.4%。 Alphabet股价下跌0.5%,此前这家谷歌
雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌!投资者涌入公用事业和消费必需品类股避险!
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
雅诗兰黛
所属市场
NYSE
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.elcompanies.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
雅诗兰黛公司由雅诗兰黛和约瑟夫·兰黛于1946年创立,是全球领先的优质护肤品、化妆品、香水和护发产品的制造商和销售商之一。公司的产品在大约150个国家和地区销售,这些品牌包括:雅诗兰黛、倩碧、Origins、M·A·C、Bobbi Brown、La Mer、Aveda、Jo Malone London、Too Faced和Dr. Jart+。公司也是香水、化妆品和各种设计师品牌销售的相关产品的全球许可证持有人。
05-22
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
05-01
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-01
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-29
超过5%披露
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
04-24
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
04-01
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
03-24
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-05
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-01
重要事件披露
Form 8-K/A - Current report: [Amend]
Form 8-K/A - Current report: [Amend]
2025-11-26
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-11-26
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-11-18
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-11-18
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-12
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
分时
5日
日
周
月
数据加载中...
最高
90.99
今开
90.85
量比
1.22
最低
88.88
昨收
90.52
换手率
2.39%
热议股票
{"pagemeta":{"title":"雅诗兰黛(EL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供雅诗兰黛(EL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"雅诗兰黛,EL,雅诗兰黛股票,雅诗兰黛股票老虎,雅诗兰黛股票老虎国际,雅诗兰黛行情,雅诗兰黛股票行情,雅诗兰黛股价,雅诗兰黛股市,雅诗兰黛股票价格,雅诗兰黛股票交易,雅诗兰黛股票购买,雅诗兰黛股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"雅诗兰黛(EL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供雅诗兰黛(EL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"EL","data":{"stockData":{"symbol":"EL","market":"US","secType":"STK","nameCN":"雅诗兰黛","latestPrice":88.95,"timestamp":1780084800000,"preClose":90.52,"halted":0,"volume":5562018,"hourTrading":{"tag":"盘后","latestPrice":88.9016,"preClose":88.95,"latestTime":"19:50 EDT","volume":799617,"amount":71127376.21865,"timestamp":1780098655291,"change":-0.0484,"changeRate":-0.000544,"amplitude":0.016076},"delay":0,"changeRate":-0.01734423331860355,"floatShares":233138397,"shares":360360240,"eps":-0.687877,"marketStatus":"休市中","change":-1.57,"latestTime":"05-29 16:00:00 EDT","open":90.85,"high":90.99,"low":88.88,"amount":497493420.74586004,"amplitude":0.02331,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.687877,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":816498000000,"exchange":"NYSE","adjPreClose":90.52,"dividendRate":0.015739,"preHourTrading":{"tag":"盘前","latestPrice":90.88,"preClose":90.52,"latestTime":"09:23 EDT","volume":1218,"amount":110635.439292,"timestamp":1780061022222,"change":0.36,"changeRate":0.003977,"amplitude":0.024911},"postHourTrading":{"tag":"盘后","latestPrice":88.9016,"preClose":88.95,"latestTime":"19:50 EDT","volume":799617,"amount":71127376.21865,"timestamp":1780098655291,"change":-0.0484,"changeRate":-0.000544,"amplitude":0.016076},"volumeRatio":1.2189909071282283,"impliedVol":0.4445,"impliedVolPercentile":0.494},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.567092763707208","cardData":[{"tweetId":"567092763707208","author":{"authorId":"3516340331928883","idStr":"3516340331928883","name":"从你的全世界路过摔了一跤","avatar":"https://static.tigerbbs.com/d0b405c7a64587f43d73918b8a31011f","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":34,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/EL\">$雅诗兰黛(EL)$ </a><v-v data-views=\"1\"></v-v> 雅诗兰黛的大涨是否代表着消费情绪的上涨📈?从宏观经济角度看现在还处于五月中下旬这市场低迷的阶段,要是端午节过后才能知道消费情绪是否反弹,谨慎做多","plainDigest":"$雅诗兰黛(EL)$ 雅诗兰黛的大涨是否代表着消费情绪的上涨📈?从宏观经济角度看现在还处于五月中下旬这市场低迷的阶段,要是端午节过后才能知道消费情绪是否反弹,谨慎做多","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1779471655563,"gmtModify":1779471773186,"symbols":["EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":361,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/567092763707208","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":155,"displayRows":4,"foldSize":0,"authorId":"3516340331928883"}]},{"cardType":"TWEET","cardId":"TWEET.564452091541504","cardData":[{"tweetId":"564452091541504","author":{"authorId":"4219291280354550","idStr":"4219291280354550","name":"星岛财经","avatar":"https://static.tigerbbs.com/f1e50b46b854117e453fd348677add8e","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":19,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"IPO前夕大额分红!雅诗兰黛供应商闯关北交所,两轮问询深挖增长真实性","digest":"雅诗兰黛 近期,国内化妆品多肽原料领域的头部企业深圳市维琪科技股份有限公司(下称“维琪科技”),顺利通过北交所上市委审核,有望冲刺A股“多肽原料第一股”。 图片 ▲资料来源:北交所 伴随A股消费类IPO政策回暖,北交所成为细分消费企业资本化的重要承接阵地。不过本次IPO进程中,维琪科技先后遭遇两轮监管问询、收入真实性被重点核查,叠加上市申报阶段大额分红、问询后大幅缩减募资规模等争议,公司经营稳定性、资本规划合理性持续受到市场关注。 针对募资调整、未来发展等相关问题,《星岛》向维琪科技发送采访函,截至发稿未获企业回复。 消费IPO迎政策窗口期 近年来A股消费企业上市审核整体趋严。2023年8月27日,中国证监会发布《证监会统筹一二级市场平衡,优化IPO、再融资监管安排》,明确提出根据近期市场情况,阶段性收紧IPO节奏,促进投融资两端的动态平衡。据第三方统计,“827”新政后,至少十余家衣食住行大消费类企业终止了A股IPO项目,不少企业转向境外资本市场递交材料。 转折点出现在2026年3月6日,中国证监会主席吴清在十四届全国人大四次会议经济主题记者会上表示,将在创业板增设一套更加精准、更为包容的上市标准,积极支持新型消费、现代服务业等优质创新创业企业在创业板发行上市。这也被外界解读为消费类IPO开闸的明确信号。 其中,北交所成为了重要承接阵地。数据显示,截至2026年4月3日,北交所排队企业共计152家,与消费服务领域相关的企业就占据23家。市场分析也指出,相较于主板、科创板,北交所财务标准更灵活,侧重考察企业成长潜力与细分竞争力,契合维琪科技这类专精特新消费原料企业的发展阶段。 资料显示,维琪科技成立于2011年,创始人为丁文锋、赖燕华夫妇。公司深耕化妆品多肽、生物活性原料领域多年,核心产品覆盖化妆品多肽原料、生物活性成分及化妆品成品,凭借技术积累切入国际高端供应链。目前,其","plainDigest":"雅诗兰黛 近期,国内化妆品多肽原料领域的头部企业深圳市维琪科技股份有限公司(下称“维琪科技”),顺利通过北交所上市委审核,有望冲刺A股“多肽原料第一股”。 图片 ▲资料来源:北交所 伴随A股消费类IPO政策回暖,北交所成为细分消费企业资本化的重要承接阵地。不过本次IPO进程中,维琪科技先后遭遇两轮监管问询、收入真实性被重点核查,叠加上市申报阶段大额分红、问询后大幅缩减募资规模等争议,公司经营稳定性、资本规划合理性持续受到市场关注。 针对募资调整、未来发展等相关问题,《星岛》向维琪科技发送采访函,截至发稿未获企业回复。 消费IPO迎政策窗口期 近年来A股消费企业上市审核整体趋严。2023年8月27日,中国证监会发布《证监会统筹一二级市场平衡,优化IPO、再融资监管安排》,明确提出根据近期市场情况,阶段性收紧IPO节奏,促进投融资两端的动态平衡。据第三方统计,“827”新政后,至少十余家衣食住行大消费类企业终止了A股IPO项目,不少企业转向境外资本市场递交材料。 转折点出现在2026年3月6日,中国证监会主席吴清在十四届全国人大四次会议经济主题记者会上表示,将在创业板增设一套更加精准、更为包容的上市标准,积极支持新型消费、现代服务业等优质创新创业企业在创业板发行上市。这也被外界解读为消费类IPO开闸的明确信号。 其中,北交所成为了重要承接阵地。数据显示,截至2026年4月3日,北交所排队企业共计152家,与消费服务领域相关的企业就占据23家。市场分析也指出,相较于主板、科创板,北交所财务标准更灵活,侧重考察企业成长潜力与细分竞争力,契合维琪科技这类专精特新消费原料企业的发展阶段。 资料显示,维琪科技成立于2011年,创始人为丁文锋、赖燕华夫妇。公司深耕化妆品多肽、生物活性原料领域多年,核心产品覆盖化妆品多肽原料、生物活性成分及化妆品成品,凭借技术积累切入国际高端供应链。目前,其","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778840078129,"gmtModify":1778840949359,"symbols":["IPOS","VIG","EL","SPCX"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":4,"images":[{"url":"https://static.tigerbbs.com/ebf5f6e732979428204da32960973fe4","width":"800","height":"533"}],"repostCount":0,"viewCount":512,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/564452091541504","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4428,"displayRows":4,"foldSize":0,"authorId":"4219291280354550"}]},{"cardType":"TWEET","cardId":"TWEET.561263427764496","cardData":[{"tweetId":"561263427764496","author":{"authorId":"3580875730323394","idStr":"3580875730323394","name":"野马财经","avatar":"https://static.tigerbbs.com/adad0aabe76ab2158365224c9b5ebd87","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":337,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛供应商维琪科技年入2亿,70后博士为上市借给前大将600万","digest":"为上市无息借给前“大将”600万元。 作者|张德宝 编辑|刘钦文 如果你陪着爱人去过化妆品店,当店员介绍产品时,你一定会听到这样的字样:这款产品不仅具有保湿功效,还兼具美白、修护、抗衰老……,但你是否知道,这些功效的背后大多离不开一种名叫活性多肽的原料。 深圳市维琪科技股份有限公司(简称“维琪科技”)便是以销售活性多肽为主的化妆品原料企业,凭借对化妆品原料的深耕,维琪科技年收入超2亿元。如今,维琪科技站在资本市场大门之外,接受资本市场“检阅”,即将迎来上会。 维琪科技的实控人为丁文锋、赖燕敏夫妇,丁文锋为博士研究生学历。为了成功上市,丁文锋“招兵买马”吸引销售干将和拉不少投资机构入股,但在上市前期一名销售总监与其经营理念不合而退出维琪科技。 而投资机构入股时则伴随着对赌协议,并约定在规定时间未通过上市审核则触发回购条款,将支付4.28亿元回购款。在此之下,丁文锋、赖燕敏能否成功叩开资本市场大门? 01 靠卖化妆品原料年收入超2亿, 丸美、宝洁系客户 根据《招股书》介绍,维琪科技的主要产品为化妆品原料、化妆品成品。其中,化妆品原料产品以皮肤活性多肽为主,化妆品成品业务包括ODM成品业务和OBM成品业务。 其中,维琪科技ODM成品业务指根据客户需求,在向客户销售公司化妆品原料的同时,使用该等原料为客户生产化妆品成品,最终目的系为促进化妆品原料推广和销售。 目前,维琪科技的客户中包含丸美、宝洁、联合利华、敷尔佳等企业。其中,丸美生物常年为维琪科技的第一、第二大客户。数据显示,报告期内,维琪科技来自丸美生物的收入为1579.31万元、2643.6万元、2052.06万元,占当期营收的比重分别为9.58%、10.68%、7.45%。 此外,来自前五大客户的销售收入分别为4858.94万元、9597.58万元、9700.85万元,占当期营收的比重分别为9.58%、10.68%、7.45","plainDigest":"为上市无息借给前“大将”600万元。 作者|张德宝 编辑|刘钦文 如果你陪着爱人去过化妆品店,当店员介绍产品时,你一定会听到这样的字样:这款产品不仅具有保湿功效,还兼具美白、修护、抗衰老……,但你是否知道,这些功效的背后大多离不开一种名叫活性多肽的原料。 深圳市维琪科技股份有限公司(简称“维琪科技”)便是以销售活性多肽为主的化妆品原料企业,凭借对化妆品原料的深耕,维琪科技年收入超2亿元。如今,维琪科技站在资本市场大门之外,接受资本市场“检阅”,即将迎来上会。 维琪科技的实控人为丁文锋、赖燕敏夫妇,丁文锋为博士研究生学历。为了成功上市,丁文锋“招兵买马”吸引销售干将和拉不少投资机构入股,但在上市前期一名销售总监与其经营理念不合而退出维琪科技。 而投资机构入股时则伴随着对赌协议,并约定在规定时间未通过上市审核则触发回购条款,将支付4.28亿元回购款。在此之下,丁文锋、赖燕敏能否成功叩开资本市场大门? 01 靠卖化妆品原料年收入超2亿, 丸美、宝洁系客户 根据《招股书》介绍,维琪科技的主要产品为化妆品原料、化妆品成品。其中,化妆品原料产品以皮肤活性多肽为主,化妆品成品业务包括ODM成品业务和OBM成品业务。 其中,维琪科技ODM成品业务指根据客户需求,在向客户销售公司化妆品原料的同时,使用该等原料为客户生产化妆品成品,最终目的系为促进化妆品原料推广和销售。 目前,维琪科技的客户中包含丸美、宝洁、联合利华、敷尔佳等企业。其中,丸美生物常年为维琪科技的第一、第二大客户。数据显示,报告期内,维琪科技来自丸美生物的收入为1579.31万元、2643.6万元、2052.06万元,占当期营收的比重分别为9.58%、10.68%、7.45%。 此外,来自前五大客户的销售收入分别为4858.94万元、9597.58万元、9700.85万元,占当期营收的比重分别为9.58%、10.68%、7.45","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778058898490,"gmtModify":1778061194127,"symbols":["IPOS","EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":8,"images":[{"url":"https://static.tigerbbs.com/ed1a60740081f2b50e4fbaa2cdb152de","width":"640","height":"272"},{"url":"https://static.tigerbbs.com/a3ccd8b46f9951aedac8055a3cad8d57","width":"640","height":"480"},{"url":"https://static.tigerbbs.com/02b5290f59cd83c3b550e99a21620b16","width":"640","height":"482"}],"repostCount":0,"viewCount":702,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/561263427764496","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":6248,"displayRows":4,"foldSize":0,"authorId":"3580875730323394"}]},{"cardType":"TWEET","cardId":"TWEET.543964839059520","cardData":[{"tweetId":"543964839059520","author":{"authorId":"4195792485940420","idStr":"4195792485940420","name":"源Sight","avatar":"https://static.tigerbbs.com/252228f4509c69dc5cc36fdeffdc64c3","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":26,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛变得越来越小气了","digest":"文源 | 源Sight 作者 | 周艺 在祖玛珑创始人和Zara合作了近7年时间后,雅诗兰黛终于坐不住了。 近日,雅诗兰黛起诉了调香师祖·玛珑、其香水品牌Jo Loves以及英国快时尚品牌Zara,原因是他们在香水营销的场景中使用了“祖·玛珑”这一姓名。 在雅诗兰黛看来,会有消费者将Zara与祖·玛珑合作的平价香水与真正的祖玛珑香水混淆,由此起诉祖・玛珑违约、商标侵权及误导消费者。 由于祖・玛珑于1999年将自己的同名香水品牌及姓名使用权出售给雅诗兰黛集团,所以严格意义上讲,任何相关字样出现在同类竞品中,哪怕仅仅说明此款香水由谁打造,也违反了合同条款。 图片来源:Zara官网 2026年,雅诗兰黛对合作伙伴的态度“严苛”了不少,2月份时因为沃尔玛对平台内假货的“放任”态度而发起诉讼;3月份则向Zara和过往品牌创始人“开炮”。 如今的雅诗兰黛还在触底复苏的关键阶段,对蚕食利润和渠道安全的仿冒品不能再视而不见,也不能对试图用平替抢占关键市场的“老同事”网开一面。 在这场降本增效、开源节流的战略行动中,雅诗兰黛大方不起来了。 01 阻断“平替”源头 合作的开始总是甜蜜的。 1999年,当时雅诗兰黛集团主席,也是后期集团的灵魂人物莱纳德意外发现了祖·玛珑生产的浴油,当时其仅仅拥有一个非常小的精品店。 被雅诗兰黛收购之后,祖·玛珑本人也长期担任该香水品牌的创意总监,直到2006年彻底离开,不仅出售了“Jo Malone London”的商标权,还签署了五年不得从事香水行业的竞业协议。 后来,这个决定被祖·玛珑认为是“人生中最大的错误”。 2011年,摆脱竞业协议的祖·玛珑迅速开设了自己的香水品牌,取名“Jo Loves”,瓶身包装与祖玛珑形成较大差别,定价上依然选择了高端奢侈品香水的赛道,部分产品价位高于祖玛珑,主打的受众群体是那些觉得祖玛珑太“大众”的资深香水玩家。 图片来源:淘","plainDigest":"文源 | 源Sight 作者 | 周艺 在祖玛珑创始人和Zara合作了近7年时间后,雅诗兰黛终于坐不住了。 近日,雅诗兰黛起诉了调香师祖·玛珑、其香水品牌Jo Loves以及英国快时尚品牌Zara,原因是他们在香水营销的场景中使用了“祖·玛珑”这一姓名。 在雅诗兰黛看来,会有消费者将Zara与祖·玛珑合作的平价香水与真正的祖玛珑香水混淆,由此起诉祖・玛珑违约、商标侵权及误导消费者。 由于祖・玛珑于1999年将自己的同名香水品牌及姓名使用权出售给雅诗兰黛集团,所以严格意义上讲,任何相关字样出现在同类竞品中,哪怕仅仅说明此款香水由谁打造,也违反了合同条款。 图片来源:Zara官网 2026年,雅诗兰黛对合作伙伴的态度“严苛”了不少,2月份时因为沃尔玛对平台内假货的“放任”态度而发起诉讼;3月份则向Zara和过往品牌创始人“开炮”。 如今的雅诗兰黛还在触底复苏的关键阶段,对蚕食利润和渠道安全的仿冒品不能再视而不见,也不能对试图用平替抢占关键市场的“老同事”网开一面。 在这场降本增效、开源节流的战略行动中,雅诗兰黛大方不起来了。 01 阻断“平替”源头 合作的开始总是甜蜜的。 1999年,当时雅诗兰黛集团主席,也是后期集团的灵魂人物莱纳德意外发现了祖·玛珑生产的浴油,当时其仅仅拥有一个非常小的精品店。 被雅诗兰黛收购之后,祖·玛珑本人也长期担任该香水品牌的创意总监,直到2006年彻底离开,不仅出售了“Jo Malone London”的商标权,还签署了五年不得从事香水行业的竞业协议。 后来,这个决定被祖·玛珑认为是“人生中最大的错误”。 2011年,摆脱竞业协议的祖·玛珑迅速开设了自己的香水品牌,取名“Jo Loves”,瓶身包装与祖玛珑形成较大差别,定价上依然选择了高端奢侈品香水的赛道,部分产品价位高于祖玛珑,主打的受众群体是那些觉得祖玛珑太“大众”的资深香水玩家。 图片来源:淘","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1773829406483,"gmtModify":1773829682844,"symbols":["EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":5,"images":[{"url":"https://static.tigerbbs.com/e3f3fb998603cbedb51cc09f9148003f","width":"1341","height":"770"}],"repostCount":0,"viewCount":1115,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/543964839059520","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4522,"displayRows":4,"foldSize":0,"authorId":"4195792485940420"}]},{"cardType":"TWEET","cardId":"TWEET.539739604645016","cardData":[{"tweetId":"539739604645016","author":{"authorId":"4219025591322210","idStr":"4219025591322210","name":"大方财经","avatar":"https://static.tigerbbs.com/7000113a144e2011728e349806cf7033","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛“变了”","digest":"有这样一家美妆巨头,从纽约第五大道的一个小柜台起步,硬是把“高端护肤”做成了全球生意,它就是雅诗兰黛。 1946年,雅诗·兰黛夫人怀揣着对美丽的执着,在纽约第五大道的高端百货中,以一款兼具香水与护肤功效的“青春之露”,敲开了高端美妆市场的大门逐渐发展成如今囊括海蓝之谜、汤姆福特等20多个品牌的美妆帝国。 数十年来,品牌始终坚守高端定位,从伦敦哈罗德百货到全球各地的专柜,从丝芙兰的专属陈列到高端免税店的核心布局,始终以“正品保障、专业品质”为核心,拒绝轻易降价,成为“精致与高端”的代名词。 回望雅诗兰黛的百年发展,其长盛不衰的核心,离不开对消费需求的洞察。从最初精准捕捉上流社会对高端护肤的需求,推出契合圈层审美的产品,到后来紧跟全球化浪潮,布局全品类、多品牌矩阵,每一步都踩准了消费趋势的脉搏。 而在当下,曾经追捧“高端”的消费者,如今更青睐“质价比”——既不愿放弃大牌品质,也不愿为柜台租金、营销费用等虚高溢价埋单。这种“既要又要”的需求,让特卖渠道逐渐崛起,也让雅诗兰黛看到了新的增长可能。 于是在2月25日,雅诗兰黛官宣入驻唯品会。原因很简单,作为特卖电商,唯品会一头解决“省钱买大牌”的现实痛点,一头也给品牌提供了更高效的触达方式:不需要靠极端降价,又能把新品认知和刚需复购覆盖到更广的人群。 比如在唯品会小棕瓶50ml到手价870元还附赠多支小样,智妍面霜75ml到手135ml仅996元,用“正装品质+加量优惠”降低了用户第一次尝试的门槛,让更多人敢试、愿意复购。 平台层面的用户结构也解释了雅诗兰黛的这一动作。唯品会业绩披露,SVIP活跃用户增至980万,并贡献线上销售额的52%。这意味着平台有一批稳定回流的高价值用户,反复在平台下单,对护肤这种高复购品类尤其重要。 除了雅诗兰黛,像兰蔻、蔻驰、巴宝莉等大牌也纷纷下注唯品会,看中的正是特卖背后的广阔蓝海。 说到底,雅诗兰黛们的","plainDigest":"有这样一家美妆巨头,从纽约第五大道的一个小柜台起步,硬是把“高端护肤”做成了全球生意,它就是雅诗兰黛。 1946年,雅诗·兰黛夫人怀揣着对美丽的执着,在纽约第五大道的高端百货中,以一款兼具香水与护肤功效的“青春之露”,敲开了高端美妆市场的大门逐渐发展成如今囊括海蓝之谜、汤姆福特等20多个品牌的美妆帝国。 数十年来,品牌始终坚守高端定位,从伦敦哈罗德百货到全球各地的专柜,从丝芙兰的专属陈列到高端免税店的核心布局,始终以“正品保障、专业品质”为核心,拒绝轻易降价,成为“精致与高端”的代名词。 回望雅诗兰黛的百年发展,其长盛不衰的核心,离不开对消费需求的洞察。从最初精准捕捉上流社会对高端护肤的需求,推出契合圈层审美的产品,到后来紧跟全球化浪潮,布局全品类、多品牌矩阵,每一步都踩准了消费趋势的脉搏。 而在当下,曾经追捧“高端”的消费者,如今更青睐“质价比”——既不愿放弃大牌品质,也不愿为柜台租金、营销费用等虚高溢价埋单。这种“既要又要”的需求,让特卖渠道逐渐崛起,也让雅诗兰黛看到了新的增长可能。 于是在2月25日,雅诗兰黛官宣入驻唯品会。原因很简单,作为特卖电商,唯品会一头解决“省钱买大牌”的现实痛点,一头也给品牌提供了更高效的触达方式:不需要靠极端降价,又能把新品认知和刚需复购覆盖到更广的人群。 比如在唯品会小棕瓶50ml到手价870元还附赠多支小样,智妍面霜75ml到手135ml仅996元,用“正装品质+加量优惠”降低了用户第一次尝试的门槛,让更多人敢试、愿意复购。 平台层面的用户结构也解释了雅诗兰黛的这一动作。唯品会业绩披露,SVIP活跃用户增至980万,并贡献线上销售额的52%。这意味着平台有一批稳定回流的高价值用户,反复在平台下单,对护肤这种高复购品类尤其重要。 除了雅诗兰黛,像兰蔻、蔻驰、巴宝莉等大牌也纷纷下注唯品会,看中的正是特卖背后的广阔蓝海。 说到底,雅诗兰黛们的","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772790437109,"gmtModify":1772790458055,"symbols":["EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/660996f1af138da83d621c5ca0d929df","width":"849","height":"650"},{"url":"https://static.tigerbbs.com/cd3bffcebe31bc7dac49a03aef4cad5d","width":"629","height":"460"},{"url":"https://static.tigerbbs.com/cca81f54c3160bda76bb39da849e5f42","width":"738","height":"417"}],"repostCount":0,"viewCount":1483,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/539739604645016","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1549,"displayRows":4,"foldSize":0,"authorId":"4219025591322210"}]},{"cardType":"TWEET","cardId":"TWEET.540355516489808","cardData":[{"tweetId":"540355516489808","author":{"authorId":"4162086877108090","idStr":"4162086877108090","name":"节点美妆","avatar":"https://static.tigerbbs.com/6b0631399dadbc8e41ff68dc050ee405","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛硬刚沃尔玛:一场美妆巨头对零售渠道的宣战","digest":"文 / 杨蕾 来源 / 节点美妆 “之前在山姆买过一次全球购海蓝之谜,包装很松垮。” “假的是无疑的,我是十年以上资深La Mer用户。” “很廉价的味道,跟专柜买的完全是两样东西。” 最近,随着雅诗兰黛一纸诉状将山姆母公司沃尔玛告上法庭,社交平台上,消费者关于在山姆、沃尔玛买到疑似假货的吐槽集中爆发。 有消费者表示曾考虑自费送检,但被告知检测结果可能不被平台采纳为退货依据;也有消费者反映遇到包装版本不符等情况,沟通解决过程较为周折。 雅诗兰黛此次对沃尔玛的诉讼,将原本零散的个人维权案例带入公众视野,引发更多消费者对高端美妆产品购买渠道的关注。 社交平台上,越来越多消费者晒出照片求助鉴定,从HR赫莲娜黑绷带面霜,到海蓝之谜精粹水,无一不是超一线品牌。 作为品牌方的雅诗兰黛,在此次事件中主动采取法律行动,引发了外界对品牌与渠道关系的讨论。 品牌方与渠道方,本是“唇齿相依”的利益共同体,雅诗兰黛的货要通过沃尔玛、山姆触达消费者,沃尔玛也需要大牌美妆撑场面。 可这一次,雅诗兰黛为何选择撕破脸,硬刚沃尔玛? 雅诗兰黛为何采取法律行动? 美国时间2月9日,雅诗兰黛在加州联邦法院对沃尔玛提起诉讼,指控其通过官方网站销售假冒的旗下香水及护肤品,涉及Le Labo勒莱柏、La Mer海蓝之谜、Clinique倩碧、Tom Ford汤姆福特等多个高客单价品牌。诉状用词极为严厉: 沃尔玛的行为“极端、恶劣、欺诈……卑鄙且有害”。 雅诗兰黛此次态度坚决,背后有多重因素考量。首先,被提及的品牌正是雅诗兰黛的增长引擎。 《节点美妆》在《仰仗中国「辣妹」,雅诗兰黛终于能松口气了》一文中分析雅诗兰黛最新的财报,这个季度雅诗兰黛净销售额增长 6%,达到42 亿美元;有机净销售额增长 4%,在本季度实现1.62亿美元盈利,较去年同期扭亏为盈。 其中香水业务以9%的增速领跑所有部门,主要由Le Labo、To","plainDigest":"文 / 杨蕾 来源 / 节点美妆 “之前在山姆买过一次全球购海蓝之谜,包装很松垮。” “假的是无疑的,我是十年以上资深La Mer用户。” “很廉价的味道,跟专柜买的完全是两样东西。” 最近,随着雅诗兰黛一纸诉状将山姆母公司沃尔玛告上法庭,社交平台上,消费者关于在山姆、沃尔玛买到疑似假货的吐槽集中爆发。 有消费者表示曾考虑自费送检,但被告知检测结果可能不被平台采纳为退货依据;也有消费者反映遇到包装版本不符等情况,沟通解决过程较为周折。 雅诗兰黛此次对沃尔玛的诉讼,将原本零散的个人维权案例带入公众视野,引发更多消费者对高端美妆产品购买渠道的关注。 社交平台上,越来越多消费者晒出照片求助鉴定,从HR赫莲娜黑绷带面霜,到海蓝之谜精粹水,无一不是超一线品牌。 作为品牌方的雅诗兰黛,在此次事件中主动采取法律行动,引发了外界对品牌与渠道关系的讨论。 品牌方与渠道方,本是“唇齿相依”的利益共同体,雅诗兰黛的货要通过沃尔玛、山姆触达消费者,沃尔玛也需要大牌美妆撑场面。 可这一次,雅诗兰黛为何选择撕破脸,硬刚沃尔玛? 雅诗兰黛为何采取法律行动? 美国时间2月9日,雅诗兰黛在加州联邦法院对沃尔玛提起诉讼,指控其通过官方网站销售假冒的旗下香水及护肤品,涉及Le Labo勒莱柏、La Mer海蓝之谜、Clinique倩碧、Tom Ford汤姆福特等多个高客单价品牌。诉状用词极为严厉: 沃尔玛的行为“极端、恶劣、欺诈……卑鄙且有害”。 雅诗兰黛此次态度坚决,背后有多重因素考量。首先,被提及的品牌正是雅诗兰黛的增长引擎。 《节点美妆》在《仰仗中国「辣妹」,雅诗兰黛终于能松口气了》一文中分析雅诗兰黛最新的财报,这个季度雅诗兰黛净销售额增长 6%,达到42 亿美元;有机净销售额增长 4%,在本季度实现1.62亿美元盈利,较去年同期扭亏为盈。 其中香水业务以9%的增速领跑所有部门,主要由Le Labo、To","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772940868913,"gmtModify":1772941712765,"symbols":["WMT","EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":5,"images":[{"url":"https://static.tigerbbs.com/2a0eae8222e90540ff6b7ef85e1efe3d","width":"1021","height":"642"},{"url":"https://static.tigerbbs.com/1eaefc9bd812b6a75427aef809a7436b","width":"1080","height":"681"},{"url":"https://static.tigerbbs.com/8a0d83c7a49e078e1496b69c1e49aa46","width":"1080","height":"463"}],"repostCount":0,"viewCount":1592,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/540355516489808","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4929,"displayRows":4,"foldSize":0,"authorId":"4162086877108090"}]},{"cardType":"TWEET","cardId":"TWEET.539580074233968","cardData":[{"tweetId":"539580074233968","author":{"authorId":"4230725200877370","idStr":"4230725200877370","name":"产业经济在线","avatar":"https://static.tigerbbs.com/76ad86800d8c65ffe4fdba978f1761f9","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛集团于2026 IMCAS 世界大会深化肌肤长寿与再生美学科研领导力","digest":" 近日,雅诗兰黛集团在 2026年 IMCAS 世界大会上发布了有关「SIRT长寿肌因」(Sirtuin)与外泌体研究的最新科学洞见。作为皮肤科、整形外科与美学领域的顶级学术盛会之一,本届IMCAS 世界大会于1月底在巴黎举办,吸引逾 2 万名参会者,汇聚了行业领军人物的最新科研成果及行业头部企业进展。大会上,集团旗下的雅诗兰黛品牌首席科学家 Rishabh Kala 博士,及海蓝之谜品牌麦克斯·贺伯研究实验室(Max Huber Research Labs)首席科学家 Jaime Emmetsberger 博士受科学委员会邀请发表专题演讲,分别展示了品牌在肌肤长寿科学与再生美学领域的科研权威。 在 Kala 博士题为《肌肤长寿科学:「SIRT长寿肌因」与线粒体健康在皮肤衰老中的科学验证作用》的演讲中,他重点介绍了雅诗兰黛在肌肤长寿科学领域超过 17 年的持续研究,凸显了品牌在该领域的领导地位。「SIRT长寿肌因」(Sirtuins)是一组与健康衰老和长寿密切相关的蛋白质家族,对细胞能量调控、压力应对及稳态维持至关重要。Kala 博士进一步阐释了「SIRT长寿肌因」与线粒体动态在维持年轻肌肤功能中的协同作用,并分享了关于「SIRT长寿肌因」激活机制及线粒体靶向技术的前沿研究进展,这些探索正推动以肌肤长寿为核心的新一代护肤科技发展。雅诗兰黛研究表明,其独有成分能够对抗因年龄增长导致的 SIRT 活性下降,通过支持可见的肌肤逆龄与韧性提升,致力于帮助肌肤细胞维持巅峰状态,保持更长久的年轻健康。 在Emmetsberger 博士题为 《释放外泌体在药妆学中的潜力:替代来源、生物学功效与挑战》的演讲中,她指出外泌体正成为化妆品科学中最受关注的新兴研究领域之一。","plainDigest":"近日,雅诗兰黛集团在 2026年 IMCAS 世界大会上发布了有关「SIRT长寿肌因」(Sirtuin)与外泌体研究的最新科学洞见。作为皮肤科、整形外科与美学领域的顶级学术盛会之一,本届IMCAS 世界大会于1月底在巴黎举办,吸引逾 2 万名参会者,汇聚了行业领军人物的最新科研成果及行业头部企业进展。大会上,集团旗下的雅诗兰黛品牌首席科学家 Rishabh Kala 博士,及海蓝之谜品牌麦克斯·贺伯研究实验室(Max Huber Research Labs)首席科学家 Jaime Emmetsberger 博士受科学委员会邀请发表专题演讲,分别展示了品牌在肌肤长寿科学与再生美学领域的科研权威。 在 Kala 博士题为《肌肤长寿科学:「SIRT长寿肌因」与线粒体健康在皮肤衰老中的科学验证作用》的演讲中,他重点介绍了雅诗兰黛在肌肤长寿科学领域超过 17 年的持续研究,凸显了品牌在该领域的领导地位。「SIRT长寿肌因」(Sirtuins)是一组与健康衰老和长寿密切相关的蛋白质家族,对细胞能量调控、压力应对及稳态维持至关重要。Kala 博士进一步阐释了「SIRT长寿肌因」与线粒体动态在维持年轻肌肤功能中的协同作用,并分享了关于「SIRT长寿肌因」激活机制及线粒体靶向技术的前沿研究进展,这些探索正推动以肌肤长寿为核心的新一代护肤科技发展。雅诗兰黛研究表明,其独有成分能够对抗因年龄增长导致的 SIRT 活性下降,通过支持可见的肌肤逆龄与韧性提升,致力于帮助肌肤细胞维持巅峰状态,保持更长久的年轻健康。 在Emmetsberger 博士题为 《释放外泌体在药妆学中的潜力:替代来源、生物学功效与挑战》的演讲中,她指出外泌体正成为化妆品科学中最受关注的新兴研究领域之一。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772751539308,"gmtModify":1772760430322,"symbols":["EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":929,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/539580074233968","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2365,"displayRows":4,"foldSize":0,"authorId":"4230725200877370"}]},{"cardType":"TWEET","cardId":"TWEET.531954237539920","cardData":[{"tweetId":"531954237539920","author":{"authorId":"3572079433999630","idStr":"3572079433999630","name":"新识研究所","avatar":"https://static.tigerbbs.com/f973b3be4669225f4f91e9ea30eec726","userType":6,"introduction":"奇偶之于无界,产业、公司、数据、产品、我们求客观表达","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":948,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛起诉沃尔玛,指控销售假冒海蓝之谜、雅诗兰黛、倩碧等美妆产品","digest":"雅诗兰黛起诉沃尔玛,指其线上平台售假冒旗下多款美妆产品 近日,雅诗兰黛集团正式向美国加州联邦法院对零售巨头沃尔玛提起诉讼,指控其线上平台销售假冒的海蓝之谜(La Mer)、雅诗兰黛、倩碧等多款核心品牌美妆产品,相关诉讼信息一经发出,迅速引发美妆与零售行业的双重关注。 雅诗兰黛在诉讼中明确要求沃尔玛立即停止侵权行为、销毁假冒产品并作出相应经济赔偿,目前具体赔偿金额尚未对外披露。 针对售假指控,双方已先后表达各自立场。据观点小知报道,沃尔玛方面作出初步回应,称公司对假冒产品持零容忍态度,将在收到法院传票后向法庭作出适当回应,但暂未对平台是否存在管控漏洞作出具体辩解。 雅诗兰黛在诉状中直指沃尔玛的管控失职,称其标榜对平台卖家的选择流程严格,且会定期审核合作卖家,却未落实正品核验的核心义务,同时将沃尔玛的行为形容为“极端、恶劣、具有欺骗性且损害严重”。 这起纠纷的背后,是高端美妆行业长期存在的售假顽疾与渠道管控痛点。据中国经济网发布的美妆鉴别相关报告显示,高端美妆假冒现象屡禁不止,2023年相关美妆检测样本的疑似假货率高达57.7%,且线上零售平台已成为售假重灾区。 目前国内美妆产品真伪鉴别尚无统一国家标准,消费者维权时难以出具官方鉴定报告,超八成买到假货的消费者最终会选择自认倒霉。而相较于品牌官方直供渠道,沃尔玛这类综合零售平台的第三方入驻模式,因卖家审核、产品溯源环节的漏洞,更易成为假冒产品的流通入口,这也是当下线上零售渠道的行业共性问题。 值得注意的是,此次雅诗兰黛起诉沃尔玛,标志着高端美妆行业的打假行动进一步升级。此次直接指向沃尔玛这样的全球零售巨头,意味着品牌方开始正式追究平台的监管连带责任。在美妆消费不断向线上转移的背景下,品牌方的维权思路已从单纯打击制假售假","plainDigest":"雅诗兰黛起诉沃尔玛,指其线上平台售假冒旗下多款美妆产品 近日,雅诗兰黛集团正式向美国加州联邦法院对零售巨头沃尔玛提起诉讼,指控其线上平台销售假冒的海蓝之谜(La Mer)、雅诗兰黛、倩碧等多款核心品牌美妆产品,相关诉讼信息一经发出,迅速引发美妆与零售行业的双重关注。 雅诗兰黛在诉讼中明确要求沃尔玛立即停止侵权行为、销毁假冒产品并作出相应经济赔偿,目前具体赔偿金额尚未对外披露。 针对售假指控,双方已先后表达各自立场。据观点小知报道,沃尔玛方面作出初步回应,称公司对假冒产品持零容忍态度,将在收到法院传票后向法庭作出适当回应,但暂未对平台是否存在管控漏洞作出具体辩解。 雅诗兰黛在诉状中直指沃尔玛的管控失职,称其标榜对平台卖家的选择流程严格,且会定期审核合作卖家,却未落实正品核验的核心义务,同时将沃尔玛的行为形容为“极端、恶劣、具有欺骗性且损害严重”。 这起纠纷的背后,是高端美妆行业长期存在的售假顽疾与渠道管控痛点。据中国经济网发布的美妆鉴别相关报告显示,高端美妆假冒现象屡禁不止,2023年相关美妆检测样本的疑似假货率高达57.7%,且线上零售平台已成为售假重灾区。 目前国内美妆产品真伪鉴别尚无统一国家标准,消费者维权时难以出具官方鉴定报告,超八成买到假货的消费者最终会选择自认倒霉。而相较于品牌官方直供渠道,沃尔玛这类综合零售平台的第三方入驻模式,因卖家审核、产品溯源环节的漏洞,更易成为假冒产品的流通入口,这也是当下线上零售渠道的行业共性问题。 值得注意的是,此次雅诗兰黛起诉沃尔玛,标志着高端美妆行业的打假行动进一步升级。此次直接指向沃尔玛这样的全球零售巨头,意味着品牌方开始正式追究平台的监管连带责任。在美妆消费不断向线上转移的背景下,品牌方的维权思路已从单纯打击制假售假","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770892604715,"gmtModify":1770902325600,"symbols":["WMT","EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":2,"images":[{"url":"https://static.tigerbbs.com/8b461cd4d8c810f62d4abae0bbe38ab2","width":"1200","height":"900"}],"repostCount":0,"viewCount":2295,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/531954237539920","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1550,"displayRows":4,"foldSize":0,"authorId":"3572079433999630"}]},{"cardType":"TWEET","cardId":"TWEET.529516038758472","cardData":[{"tweetId":"529516038758472","author":{"authorId":"3463446769405484","idStr":"3463446769405484","name":"千倍之路","avatar":"https://static.tigerbbs.com/4872d62b52bc24d392619a9db00f4808","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.09","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1309,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/EL\">$雅诗兰黛(EL)$ </a> 川普还不出手救你的好友?","plainDigest":"$雅诗兰黛(EL)$ 川普还不出手救你的好友?","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770297258600,"gmtModify":1770297261810,"symbols":["EL"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/07a34e84edf34c68d0c1df0e61a14655","width":"1080","height":"2566"}],"repostCount":0,"viewCount":1362,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/529516038758472","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":37,"displayRows":4,"foldSize":0,"authorId":"3463446769405484"}]},{"cardType":"TWEET","cardId":"TWEET.529787610686032","cardData":[{"tweetId":"529787610686032","author":{"authorId":"3570579687079753","idStr":"3570579687079753","name":"国际投行研究报告","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":2,"introduction":"凌通社,读书笔记,专业财经研究。","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1175,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌!投资者涌入公用事业和消费必需品类股避险!","digest":"雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌! 疲软的劳动力市场数据和对AI的忧虑进一步拉低美国股市,标普500指数年内转跌。软件股也再次大幅下跌;比特币下跌13%,拖累Strategy股价下跌19%。 对增长的担忧周四搅动华尔街,劳动力市场出现疲软迹象,引发美国股市又一天的大幅下跌。 来自政府和私营部门的三份报告显示去年12月份职位空缺意外偏低、上周初申请失业救济人数出人意料高企以及上个月企业裁员人数急剧增加。数据公布后,美国股市普遍下跌。 虽然近期跌势一直集中在市场上一些增长最快的股票类别,但周四的走势冲击了一些之前表现较为坚挺的实体经济类股。与消费者非必需性支出相关的股票跌幅尤其严重,DoorDash下跌6.1%。Lululemon和Ralph Lauren均下跌超过4%。 道琼斯指数下跌近600点,跌幅约1.2%。标普500指数也下跌1.2%,2026年转为下跌。美国国债价格上扬,10年期美国国债收益率随之创下去年10月份以来最大单日跌幅,降至4.209%。 但科技股和华尔街更具投机性的押注也再度下挫。纳斯达克综合指数下跌1.6%,延续了自去年4月份关税冲击以来的最严重跌势。软件股再次大幅下跌。比特币下跌13%,拖累Coinbase创下连续第13个交易日下跌的纪录,并导致比特币囤积公司Strategy股价下跌19%。白银下跌9.1%。 贝雅(Baird)投资策略师罗斯·梅菲尔德(Ross Mayfield)说:“这肯定有一种‘泥沙俱下’的效应。” 标普500指数信息技术板块下跌1.7%。微软(Microsoft)下跌5%,Salesforce回落4.7%。这轮跌势继续冲击半导体公司,包括Advanced Micro Devices,该公司收盘下跌3.9%;以及英伟达(Nvidia),该公司收盘下跌1.4%。 Alphabet股价下跌0.5%,此前这家谷歌","plainDigest":"雅诗兰黛下跌19% 增长恐慌拖累美股再次下跌! 疲软的劳动力市场数据和对AI的忧虑进一步拉低美国股市,标普500指数年内转跌。软件股也再次大幅下跌;比特币下跌13%,拖累Strategy股价下跌19%。 对增长的担忧周四搅动华尔街,劳动力市场出现疲软迹象,引发美国股市又一天的大幅下跌。 来自政府和私营部门的三份报告显示去年12月份职位空缺意外偏低、上周初申请失业救济人数出人意料高企以及上个月企业裁员人数急剧增加。数据公布后,美国股市普遍下跌。 虽然近期跌势一直集中在市场上一些增长最快的股票类别,但周四的走势冲击了一些之前表现较为坚挺的实体经济类股。与消费者非必需性支出相关的股票跌幅尤其严重,DoorDash下跌6.1%。Lululemon和Ralph Lauren均下跌超过4%。 道琼斯指数下跌近600点,跌幅约1.2%。标普500指数也下跌1.2%,2026年转为下跌。美国国债价格上扬,10年期美国国债收益率随之创下去年10月份以来最大单日跌幅,降至4.209%。 但科技股和华尔街更具投机性的押注也再度下挫。纳斯达克综合指数下跌1.6%,延续了自去年4月份关税冲击以来的最严重跌势。软件股再次大幅下跌。比特币下跌13%,拖累Coinbase创下连续第13个交易日下跌的纪录,并导致比特币囤积公司Strategy股价下跌19%。白银下跌9.1%。 贝雅(Baird)投资策略师罗斯·梅菲尔德(Ross Mayfield)说:“这肯定有一种‘泥沙俱下’的效应。” 标普500指数信息技术板块下跌1.7%。微软(Microsoft)下跌5%,Salesforce回落4.7%。这轮跌势继续冲击半导体公司,包括Advanced Micro Devices,该公司收盘下跌3.9%;以及英伟达(Nvidia),该公司收盘下跌1.4%。 Alphabet股价下跌0.5%,此前这家谷歌","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770338580000,"gmtModify":1770364861979,"symbols":["IWO","RWM","EL","TWM","LU0690374961.EUR","LU2404859741.USD","UWM","LU2404859667.USD","LU0690374615.EUR","FT_SY_MNQ","TZA","VT","LU2552382058.USD","SRTY","LU2552382215.SGD","TNA","LU2552382132.HKD","159301","IWN","IWM"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/44e99baacda3460296146f78ed156325"}],"repostCount":0,"viewCount":2111,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/529787610686032","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1834,"displayRows":4,"foldSize":0,"authorId":"3570579687079753"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21303957","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000022-EL","pdf_url":"","pub_time":1779422400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"EL","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000022/0001001250-26-000022-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000022/el-20260323.htm","primary":true,"translateUrl":"","linkName":"el-20260323.htm","type":"8-K/A","id":"NTFILE79QntpXik6QqeXLp","market":"us","size":28679},{"description":"EX-99.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000022/exhibitmay2026.htm","primary":false,"translateUrl":"","linkName":"exhibitmay2026.htm","type":"EX-99.1","id":"NTFILE5DbU1vRufpnpoLMz","market":"us","size":11077},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000022/footer.jpg","primary":false,"translateUrl":"","linkName":"footer.jpg","type":"GRAPHIC","id":"NTFILE4yMzN4Jx9fxW91Qy","market":"us","size":11003}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-22 12:00","pubTimestamp":1779422400,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21200502","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000019-EL","pdf_url":"","pub_time":1777608000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"EL","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/0001001250-26-000019-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-20260331.htm","primary":true,"translateUrl":"","linkName":"el-20260331.htm","type":"10-Q","id":"NTFILE3c8FaR6sEe6Cq84v","market":"us","size":2916850},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-q3fy2026xex311.htm","primary":false,"translateUrl":"","linkName":"el-q3fy2026xex311.htm","type":"EX-31.1","id":"NTFILEJCWLHaYERPEpPc5T","market":"us","size":9418},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-q3fy2026xex312.htm","primary":false,"translateUrl":"","linkName":"el-q3fy2026xex312.htm","type":"EX-31.2","id":"NTFILE69ZAryTtfP885FqK","market":"us","size":9701},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-q3fy2026xex321.htm","primary":false,"translateUrl":"","linkName":"el-q3fy2026xex321.htm","type":"EX-32.1","id":"NTFILEFBfMj7WGwbJMne1H","market":"us","size":4739},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000019/el-q3fy2026xex322.htm","primary":false,"translateUrl":"","linkName":"el-q3fy2026xex322.htm","type":"EX-32.2","id":"NTFILEHCJj1EXUAayrsUaq","market":"us","size":4551}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-01 12:00","pubTimestamp":1777608000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21200498","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000017-EL","pdf_url":"","pub_time":1777608000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"EL","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000017/0001001250-26-000017-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000017/fy2026q3exhibit991.htm","primary":true,"translateUrl":"","linkName":"fy2026q3exhibit991.htm","type":"EX-99.1","id":"NTFILE5GxekS1DWD63HRjy","market":"us","size":656709},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000017/el-20260501.htm","primary":false,"translateUrl":"","linkName":"el-20260501.htm","type":"8-K","id":"NTFILEFcMYjecFjY7YKGvq","market":"us","size":27423},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000017/footer.jpg","primary":false,"translateUrl":"","linkName":"footer.jpg","type":"GRAPHIC","id":"NTFILE8DNpGrSigx6DdW1w","market":"us","size":11003}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-01 12:00","pubTimestamp":1777608000,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项:经营业绩和财务状况;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21191061","market":"us","labels":[],"media":"sec.gov","original_id":"AN210011926000534-EL","pdf_url":"","pub_time":1777435200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"EL","title":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000210011926000534/0002100119-26-000534-index.htm","us_notice_code":"Form SCHEDULE 13G","us_title_en":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000210011926000534/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G","id":"NTFILE3h4ZVPMzD8KXbXqU","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-04-29 12:00","pubTimestamp":1777435200,"title_zh":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21102360","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926048256-EL","pdf_url":"","pub_time":1777003200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"EL","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000110465926048256/0001104659-26-048256-index.htm","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/942617/000110465926048256/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILE3yDLUu4bvB9AGvAk","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-04-24 12:00","pubTimestamp":1777003200,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20947031","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000013-EL","pdf_url":"","pub_time":1775016000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"EL","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000013/0001001250-26-000013-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000013/el-20240201.htm","primary":true,"translateUrl":"","linkName":"el-20240201.htm","type":"8-K/A","id":"NTFILE6VncUnkZKP49JrXB","market":"us","size":69180}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-01 12:00","pubTimestamp":1775016000,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20881393","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000010-EL","pdf_url":"","pub_time":1774304695000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"EL","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/0001001250-26-000010-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000010/exhibit991_march2026.htm","primary":true,"translateUrl":"","linkName":"exhibit991_march2026.htm","type":"EX-99.1","id":"NTFILENd5fq7va2m6GBLBU","market":"us","size":8079},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000010/el-20260323.htm","primary":false,"translateUrl":"","linkName":"el-20260323.htm","type":"8-K","id":"NTFILEAjmhmppkAcDYmybV","market":"us","size":28290},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000010/footera.jpg","primary":false,"translateUrl":"","linkName":"footera.jpg","type":"GRAPHIC","id":"NTFILEABhuCYfrtLGj484p","market":"us","size":11003}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-24 06:24","pubTimestamp":1774304695,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20704411","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000006-EL","pdf_url":"","pub_time":1770267600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"EL","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/0001001250-26-000006-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/el-20251231.htm","primary":true,"translateUrl":"","linkName":"el-20251231.htm","type":"10-Q","id":"NTFILE7mtox1w3cZiazxcg","market":"us","size":2888610},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/el-q2fy2026xex311.htm","primary":false,"translateUrl":"","linkName":"el-q2fy2026xex311.htm","type":"EX-31.1","id":"NTFILED6YtUGNP2zQVjGU5","market":"us","size":9423},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/el-q2fy2026xex312.htm","primary":false,"translateUrl":"","linkName":"el-q2fy2026xex312.htm","type":"EX-31.2","id":"NTFILECLxpJNknC45SzBYW","market":"us","size":9706},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/el-q2fy2026xex321.htm","primary":false,"translateUrl":"","linkName":"el-q2fy2026xex321.htm","type":"EX-32.1","id":"NTFILE352jW8MKyWQVJETG","market":"us","size":4747},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000006/el-q2fy2026xex322.htm","primary":false,"translateUrl":"","linkName":"el-q2fy2026xex322.htm","type":"EX-32.2","id":"NTFILEBBc7uZchdATEFhWv","market":"us","size":4559}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-02-05 13:00","pubTimestamp":1770267600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20703978","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125026000004-EL","pdf_url":"","pub_time":1770267600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"EL","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000004/0001001250-26-000004-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000004/fy2026q2exhibit991.htm","primary":true,"translateUrl":"","linkName":"fy2026q2exhibit991.htm","type":"EX-99.1","id":"NTFILEA4A9uzzALNxZmZxA","market":"us","size":604202},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000004/el-20260205.htm","primary":false,"translateUrl":"","linkName":"el-20260205.htm","type":"8-K","id":"NTFILE4DypvgtNyXDzNFbR","market":"us","size":26208},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125026000004/footer.jpg","primary":false,"translateUrl":"","linkName":"footer.jpg","type":"GRAPHIC","id":"NTFILEDwEBs3EFzneGDMpc","market":"us","size":11003}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-05 13:00","pubTimestamp":1770267600,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项:经营业绩和财务状况;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20473832","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125025000115-EL","pdf_url":"","pub_time":1764565200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"EL","title":"Form 8-K/A - Current report: [Amend]","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000115/0001001250-25-000115-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000115/el-20240201.htm","primary":true,"translateUrl":"","linkName":"el-20240201.htm","type":"8-K/A","id":"NTFILE25MDfnFvkNsEV34u","market":"us","size":61411}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-12-01 13:00","pubTimestamp":1764565200,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20455468","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004725009398-EL","pdf_url":"","pub_time":1764133200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"EL","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009398/0001950047-25-009398-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009398/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEHVEBVm3dmcjqMDrn","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-11-26 13:00","pubTimestamp":1764133200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20455444","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004725009397-EL","pdf_url":"","pub_time":1764133200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"EL","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009397/0001950047-25-009397-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009397/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEBJVqkZogQKYQz9rV","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-11-26 13:00","pubTimestamp":1764133200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20425494","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004725009008-EL","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"EL","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009008/0001950047-25-009008-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725009008/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEGfiCpyP9s3qYLckx","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20425418","market":"us","labels":[],"media":"sec.gov","original_id":"AN100125025000112-EL","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"EL","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/0001001250-25-000112-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-3.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi.htm","primary":true,"translateUrl":"","linkName":"exhibit31restatedcertifi.htm","type":"EX-3.1","id":"NTFILEHt2Yd7JbiiSJWa78","market":"us","size":58458},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/el-20251113.htm","primary":false,"translateUrl":"","linkName":"el-20251113.htm","type":"8-K","id":"NTFILEFadLDmkPmKo7DdpE","market":"us","size":52272},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi001.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi001.jpg","type":"GRAPHIC","id":"NTFILEFK92AnM9v83VuR2a","market":"us","size":191873},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi002.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi002.jpg","type":"GRAPHIC","id":"NTFILE7KBqQJyZevsX4QeK","market":"us","size":289506},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi003.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi003.jpg","type":"GRAPHIC","id":"NTFILEGKgihnDnvni9g6q5","market":"us","size":332694},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi004.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi004.jpg","type":"GRAPHIC","id":"NTFILEBwJLp2ozHtuNdv2s","market":"us","size":267029},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi005.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi005.jpg","type":"GRAPHIC","id":"NTFILE5BLQx1jT8x252pXH","market":"us","size":296093},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi006.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi006.jpg","type":"GRAPHIC","id":"NTFILEEqGLiokFjCPkYqtB","market":"us","size":320618},{"description":"","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi007.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi007.jpg","type":"GRAPHIC","id":"NTFILEJ5mCLN6wa9YF4vy2","market":"us","size":298207},{"description":"","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi008.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi008.jpg","type":"GRAPHIC","id":"NTFILE2T6nnMrXzuqGizJu","market":"us","size":287360},{"description":"","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi009.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi009.jpg","type":"GRAPHIC","id":"NTFILE5Xq5dnYyqd1JySQN","market":"us","size":294088},{"description":"","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi010.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi010.jpg","type":"GRAPHIC","id":"NTFILE8V8E2PBnpDn1nS6a","market":"us","size":278880},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi011.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi011.jpg","type":"GRAPHIC","id":"NTFILE7wSAcEJ6eTzEHaAJ","market":"us","size":276013},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi012.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi012.jpg","type":"GRAPHIC","id":"NTFILEG1PZ4ePchTDuoJaT","market":"us","size":272723},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi013.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi013.jpg","type":"GRAPHIC","id":"NTFILE6x2wTDAhjQTmXaa3","market":"us","size":258230},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi014.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi014.jpg","type":"GRAPHIC","id":"NTFILEGs3kLAQpPo2SNA4t","market":"us","size":259624},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi015.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi015.jpg","type":"GRAPHIC","id":"NTFILE9ubAczDBpSounuFd","market":"us","size":49729},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000100125025000112/exhibit31restatedcertifi016.jpg","primary":false,"translateUrl":"","linkName":"exhibit31restatedcertifi016.jpg","type":"GRAPHIC","id":"NTFILE3MZmhoFcDdipcHNG","market":"us","size":173637}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目5.07:将事项提交证券持有人表决;项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20398995","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004725008729-EL","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"EL","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725008729/0001950047-25-008729-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1001250/000195004725008729/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE9vqFPMfLgk4p9qat","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.elcompanies.com","stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.1752},{"period":"3month","weight":-0.1874},{"period":"6month","weight":-0.0544},{"period":"1year","weight":0.2953},{"period":"ytd","weight":-0.1506}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"雅诗兰黛公司由雅诗兰黛和约瑟夫·兰黛于1946年创立,是全球领先的优质护肤品、化妆品、香水和护发产品的制造商和销售商之一。公司的产品在大约150个国家和地区销售,这些品牌包括:雅诗兰黛、倩碧、Origins、M·A·C、Bobbi Brown、La Mer、Aveda、Jo Malone London、Too Faced和Dr. Jart+。公司也是香水、化妆品和各种设计师品牌销售的相关产品的全球许可证持有人。","yearOnYearQuotes":[{"month":1,"riseRate":0.548387,"avgChangeRate":0.005626},{"month":2,"riseRate":0.612903,"avgChangeRate":0.016229},{"month":3,"riseRate":0.709677,"avgChangeRate":0.017316},{"month":4,"riseRate":0.645161,"avgChangeRate":0.020492},{"month":5,"riseRate":0.612903,"avgChangeRate":0.003412},{"month":6,"riseRate":0.5,"avgChangeRate":0.015893},{"month":7,"riseRate":0.4,"avgChangeRate":-0.010773},{"month":8,"riseRate":0.4,"avgChangeRate":-0.005033},{"month":9,"riseRate":0.433333,"avgChangeRate":-0.026304},{"month":10,"riseRate":0.6,"avgChangeRate":0.016379},{"month":11,"riseRate":0.666667,"avgChangeRate":0.032694},{"month":12,"riseRate":0.709677,"avgChangeRate":0.034381}],"exchange":"NYSE","name":"雅诗兰黛","nameEN":"Estee Lauder"},"aProfile":null}}}